GALT GALECTIN THERAPEUTICS INC
Nasdaq · SEC CIK 1133416 · EDGAR
- Bought, last 12 months
- $64.6K 6 purchases by 2 insiders
- Sold, last 12 months
- $6.99M 28 sales by 6 insiders
- Filings on record
- 228 since 2021-07-02, latest 2026-08-04 07:52
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| 10X Capital Management, LLC | 10% | — | $2.23M |
| Shlevin Harold H. | Dir | — | $1.56M |
| Jamil Khurram | Chief Medical Off | — | $1.44M |
| CALLICUTT JACK W | CFO | — | $944.3K |
| LEWIS JOEL | Pres, CEO, Dir | — | $620.9K |
| CZIRR JAMES C | 10% | — | $204.3K |
| FREEMAN KEVIN D | Dir | $58.6K | — |
| ELDRED KARY | Dir | $6,032 | — |
| Uihlein Richard E | Dir, 10% | — | — |
Transactions 199
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-08-04 07:52 | 2026-07-31 | GALT | Uihlein Richard E | Dir, 10% | M - OptEx | $3.08 | +34.38M | 44.71M | +333% | +$105.81M |
| DT | 2026-07-16 17:39 | 2026-07-14 | GALT | Jamil Khurram | Chief Medical Off | M - OptEx | $3.04 | +16.2K | 16.2K | New | +$49.4K |
| DT | 2026-07-16 17:39 | 2026-07-14 | GALT | Jamil Khurram | Chief Medical Off | S - Sale+OE | $5.13 | -16.2K | 0 | -100% | -$83.3K |
| DMT | 2026-06-30 19:24 | 2026-06-26+ | GALT | Shlevin Harold H. | Dir | M - OptEx | $1.23 | +30.0K | 28.8K | New | +$36.9K |
| DMT | 2026-06-30 19:24 | 2026-06-26+ | GALT | Shlevin Harold H. | Dir | S - Sale+OE | $5.03 | -30.0K | 6,500 | -82% | -$150.9K |
| DMT | 2026-06-30 19:23 | 2026-06-26+ | GALT | Jamil Khurram | Chief Medical Off | M - OptEx | $2.49 | +52.0K | 47.5K | New | +$129.5K |
| DMT | 2026-06-30 19:23 | 2026-06-26+ | GALT | Jamil Khurram | Chief Medical Off | S - Sale+OE | $5.04 | -52.0K | 0 | -100% | -$262.1K |
| DT | 2026-06-25 16:06 | 2026-06-23 | GALT | Jamil Khurram | Chief Medical Off | M - OptEx | $1.23 | +7,557 | 7,557 | New | +$9,295 |
| DT | 2026-06-25 16:06 | 2026-06-23 | GALT | Jamil Khurram | Chief Medical Off | S - Sale+OE | $3.14 | -7,557 | 0 | -100% | -$23.7K |
| DT | 2026-05-28 09:13 | 2026-05-26 | GALT | Jamil Khurram | Chief Medical Off | M - OptEx | $1.23 | +568 | 568 | New | +$698.64 |
| DT | 2026-05-28 09:13 | 2026-05-26 | GALT | Jamil Khurram | Chief Medical Off | S - Sale+OE | $3.10 | -568 | 0 | -100% | -$1,761 |
| 2026-02-09 | 2026-02-06 | GALT | ELDRED KARY | Dir | P - Purchase | $2.70 | +300 | 65.7K | +0.5% | +$810 | |
| D | 2026-01-21 | 2026-01-16 | GALT | Uihlein Richard E | Dir, 10% | A - Grant | $3.04 | +13.2K | 10.33M | +0.1% | +$40.0K |
| DMT | 2026-01-06 | 2026-01-02+ | GALT | Jamil Khurram | Chief Medical Off | S - Sale+OE | $3.88 | -60.0K | 21.4K | -74% | -$232.6K |
| DT | 2026-01-06 | 2026-01-02 | GALT | Jamil Khurram | Chief Medical Off | M - OptEx | $0.00 | +60.0K | 60.0K | New | $0 |
| DT | 2026-01-06 | 2026-01-02 | GALT | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $0.00 | +84.0K | 916.6K | +10% | $0 |
| DMT | 2026-01-06 | 2026-01-02+ | GALT | LEWIS JOEL | Pres, CEO, Dir | S - Sale+OE | $3.83 | -84.0K | 870.3K | -9% | -$321.4K |
| DT | 2026-01-06 | 2026-01-02 | GALT | CALLICUTT JACK W | CFO | M - OptEx | $0.00 | +60.0K | 67.6K | +788% | $0 |
| DMT | 2026-01-06 | 2026-01-02+ | GALT | CALLICUTT JACK W | CFO | S - Sale+OE | $3.89 | -60.0K | 53.7K | -53% | -$233.5K |
| DT | 2026-01-05 | 2025-12-31 | GALT | Jamil Khurram | Chief Medical Off | M - OptEx | $1.23 | +8,125 | 8,125 | New | +$9,994 |
| DT | 2026-01-05 | 2025-12-31 | GALT | Jamil Khurram | Chief Medical Off | S - Sale+OE | $4.07 | -8,125 | 0 | -100% | -$33.1K |
| T | 2025-12-23 | 2025-12-23 | GALT | FREEMAN KEVIN D | Dir | P - Purchase | $3.55 | +5,500 | 55.3K | +11% | +$19.5K |
| 2025-12-23 | 2025-12-23 | GALT | ELDRED KARY | Dir | P - Purchase | $3.73 | +700 | 65.4K | +1% | +$2,611 | |
| A | 2025-12-23 | 2025-12-23 | GALT | FREEMAN KEVIN D | Dir | P - Purchase | $3.55 | +5,500 | 55.3K | +11% | +$19.5K |
| AT | 2025-12-23 | 2025-12-23 | GALT | FREEMAN KEVIN D | Dir | P - Purchase | $3.55 | +5,500 | 55.3K | +11% | +$19.5K |
| T | 2025-12-23 | 2025-12-23 | GALT | ELDRED KARY | Dir | P - Purchase | $3.73 | +700 | 65.4K | +1% | +$2,611 |
| DMT | 2025-12-19 | 2025-12-17 | GALT | Jamil Khurram | Chief Medical Off | M - OptEx | $2.37 | +15.0K | 8,500 | New | +$35.5K |
| DMT | 2025-12-19 | 2025-12-17 | GALT | Jamil Khurram | Chief Medical Off | S - Sale+OE | $7.04 | -19.4K | 0 | -100% | -$136.9K |
| DT | 2025-12-19 | 2025-12-17 | GALT | LEWIS JOEL | Pres, CEO, Dir | S - Sale+OE | $7.06 | -7,829 | 832.6K | -0.9% | -$55.3K |
| DT | 2025-12-19 | 2025-12-17 | GALT | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $2.86 | +7,829 | 840.4K | +0.9% | +$22.4K |
| DT | 2025-12-19 | 2025-12-17 | GALT | Shlevin Harold H. | Dir | M - OptEx | $1.98 | +20.0K | 31.2K | +178% | +$39.6K |
| DMT | 2025-12-19 | 2025-12-17 | GALT | Shlevin Harold H. | Dir | S - Sale+OE | $7.04 | -24.5K | 11.2K | -69% | -$172.5K |
| 2025-12-18 | 2025-11-24 | GALT | CZIRR JAMES C | 10% | J - Other | — | -24.0K | 5.65M | -0.4% | — | |
| 2025-12-18 | 2025-12-16 | GALT | CZIRR JAMES C | 10% | S - Sale | $6.66 | -30.7K | 5.61M | -0.5% | -$204.3K | |
| DMT | 2025-12-16 | 2025-12-12+ | GALT | Shlevin Harold H. | Dir | S - Sale+OE | $6.28 | -28.2K | 11.2K | -72% | -$177.1K |
| DMT | 2025-12-16 | 2025-12-12+ | GALT | Shlevin Harold H. | Dir | M - OptEx | $4.16 | +28.2K | 19.6K | New | +$117.4K |
| DMT | 2025-12-10 | 2025-12-08+ | GALT | Shlevin Harold H. | Dir | M - OptEx | $2.27 | +171.8K | 28.0K | New | +$390.8K |
| DMT | 2025-12-10 | 2025-12-08+ | GALT | Shlevin Harold H. | Dir | S - Sale+OE | $6.00 | -175.8K | 11.2K | -94% | -$1.06M |
| MA | 2025-12-08 | 2025-12-02+ | GALT | 10X Capital Management, LLC | 10% | S - Sale | $5.68 | -162.1K | 5.67M | -3% | -$920.9K |
| M | 2025-12-04 | 2025-12-02+ | GALT | 10X Capital Management, LLC | 10% | S - Sale | $5.68 | -150.0K | 5.68M | -3% | -$851.7K |
| DMT | 2025-11-19 | 2025-11-17+ | GALT | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $2.39 | +22.5K | 839.4K | +3% | +$53.7K |
| DMT | 2025-11-19 | 2025-11-17+ | GALT | LEWIS JOEL | Pres, CEO, Dir | S - Sale+OE | $6.07 | -22.5K | 832.6K | -3% | -$136.4K |
| DMT | 2025-11-19 | 2025-11-17+ | GALT | CALLICUTT JACK W | CFO | M - OptEx | $1.53 | +77.9K | 25.8K | New | +$119.6K |
| DMT | 2025-11-19 | 2025-11-17+ | GALT | CALLICUTT JACK W | CFO | S - Sale+OE | $6.14 | -77.9K | 7,614 | -91% | -$478.7K |
| DMT | 2025-11-14 | 2025-11-13 | GALT | Jamil Khurram | Chief Medical Off | M - OptEx | $2.17 | +99.2K | 46.0K | New | +$215.0K |
| DMT | 2025-11-14 | 2025-11-13 | GALT | Jamil Khurram | Chief Medical Off | S - Sale+OE | $5.47 | -121.1K | 4,479 | -96% | -$662.5K |
| 2025-11-12 | 2025-11-11 | GALT | 10X Capital Management, LLC | 10% | S - Sale | $5.25 | -40.0K | 5.83M | -0.7% | -$210.0K | |
| DT | 2025-11-12 | 2025-11-10 | GALT | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $2.39 | +1,867 | 834.5K | +0.2% | +$4,462 |
| DT | 2025-11-12 | 2025-11-10 | GALT | LEWIS JOEL | Pres, CEO, Dir | S - Sale+OE | $6.03 | -1,867 | 832.6K | -0.2% | -$11.3K |
| DMT | 2025-11-12 | 2025-11-10 | GALT | CALLICUTT JACK W | CFO | M - OptEx | $1.46 | +5,291 | 9,694 | +120% | +$7,717 |
| DMT | 2025-11-12 | 2025-11-10 | GALT | CALLICUTT JACK W | CFO | S - Sale+OE | $6.03 | -5,291 | 7,614 | -41% | -$31.9K |
| DMT | 2025-11-07 | 2025-11-05 | GALT | CALLICUTT JACK W | CFO | S - Sale+OE | $6.00 | -600 | 7,614 | -7% | -$3,600 |
| DMT | 2025-11-07 | 2025-11-05 | GALT | CALLICUTT JACK W | CFO | M - OptEx | $1.60 | +600 | 7,814 | +8% | +$962 |
| DT | 2025-11-07 | 2025-11-05 | GALT | LEWIS JOEL | Pres, CEO, Dir | S - Sale+OE | $6.00 | -200 | 832.6K | -0.0% | -$1,200 |
| DT | 2025-11-07 | 2025-11-05 | GALT | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $2.39 | +200 | 832.8K | +0.0% | +$478 |
| DMT | 2025-11-05 | 2025-11-03+ | GALT | CALLICUTT JACK W | CFO | M - OptEx | $1.61 | +32.4K | 8,874 | New | +$52.2K |
| DMT | 2025-11-05 | 2025-11-03+ | GALT | CALLICUTT JACK W | CFO | S - Sale+OE | $6.06 | -32.4K | 7,614 | -81% | -$196.7K |
| DMT | 2025-11-05 | 2025-11-03+ | GALT | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $2.39 | +15.7K | 847.0K | +2% | +$37.6K |
| DMT | 2025-11-05 | 2025-11-03+ | GALT | LEWIS JOEL | Pres, CEO, Dir | S - Sale+OE | $6.07 | -15.7K | 832.6K | -2% | -$95.3K |
| M | 2025-10-24 | 2025-10-22 | GALT | 10X Capital Management, LLC | 10% | S - Sale | $4.94 | -50.0K | 5.90M | -0.8% | -$246.8K |
| DT | 2025-09-15 | 2025-09-12 | GALT | CALLICUTT JACK W | CFO | M - OptEx | $1.37 | +8,706 | 16.3K | +114% | +$11.9K |
| DT | 2025-09-15 | 2025-09-12 | GALT | CALLICUTT JACK W | CFO | S - Sale+OE | $6.44 | -8,706 | 7,614 | -53% | -$56.1K |
| DT | 2025-09-15 | 2025-09-12 | GALT | LEWIS JOEL | Pres, CEO, Dir | S - Sale+OE | $6.36 | -14.0K | 832.6K | -2% | -$89.0K |
| DT | 2025-09-15 | 2025-09-12 | GALT | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $2.39 | +14.0K | 846.6K | +2% | +$33.5K |
| 2025-07-22 | 2025-07-21 | GALT | ELDRED KARY | Dir | P - Purchase | $2.93 | +1,000 | 64.7K | +2% | +$2,930 | |
| 2025-07-18 | 2025-07-17 | GALT | FREEMAN KEVIN D | Dir | P - Purchase | $2.90 | +5,000 | 49.8K | +11% | +$14.5K | |
| DM | 2025-06-11 | 2025-06-06 | GALT | CZIRR JAMES C | 10% | M - OptEx | $2.16 | +323.1K | 965.5K | +50% | +$699.3K |
| DM | 2025-06-11 | 2025-02-03+ | GALT | CZIRR JAMES C | 10% | G - Gift | — | -20.0K | 721.4K | -3% | — |
| D | 2025-06-11 | 2025-03-31 | GALT | CZIRR JAMES C | 10% | J - Other | $6.00 | +1,000 | 722.4K | +0.1% | +$6,000 |
| 2025-03-05 | 2025-03-03 | GALT | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.57 | -56.4K | 832.6K | -6% | -$88.6K | |
| D | 2025-01-27 | 2025-01-23 | GALT | Uihlein Richard E | Dir, 10% | A - Grant | $1.23 | +32.5K | 10.30M | +0.3% | +$40.0K |
| 2024-12-31 | 2024-12-30 | GALT | Shlevin Harold H. | Dir | P - Purchase | $1.16 | +6,500 | 15.2K | +75% | +$7,540 | |
| 2024-12-26 | 2024-12-24 | GALT | FREEMAN KEVIN D | Dir | P - Purchase | $0.81 | +10.0K | 44.8K | +29% | +$8,100 | |
| DT | 2024-12-26 | 2024-12-23 | GALT | CALLICUTT JACK W | CFO | M - OptEx | $0.00 | +40.0K | 47.6K | +525% | $0 |
| DT | 2024-12-26 | 2024-12-23 | GALT | CALLICUTT JACK W | CFO | S - Sale+OE | $0.89 | -40.0K | 7,614 | -84% | -$35.6K |
| 2024-12-26 | 2024-12-24 | GALT | Zordani Richard A. Jr. | Dir | P - Purchase | $0.82 | +10.0K | 42.1K | +31% | +$8,200 | |
| DT | 2024-12-26 | 2024-12-23 | GALT | LEWIS JOEL | Pres, CEO, Dir | S - Sale+OE | $0.89 | -56.0K | 897.0K | -6% | -$49.8K |
| DT | 2024-12-26 | 2024-12-23 | GALT | LEWIS JOEL | Pres, CEO, Dir | M - OptEx | $0.00 | +56.0K | 953.0K | +6% | $0 |
| 2024-12-26 | 2024-12-24 | GALT | ELDRED KARY | Dir | P - Purchase | $0.82 | +13.5K | 63.7K | +27% | +$11.0K | |
| DT | 2024-12-26 | 2024-12-23 | GALT | Jamil Khurram | Chief Medical Off | M - OptEx | $0.00 | +40.0K | 40.0K | New | $0 |
| DT | 2024-12-26 | 2024-12-23 | GALT | Jamil Khurram | Chief Medical Off | S - Sale+OE | $0.88 | -13.7K | 26.3K | -34% | -$12.0K |
| 2024-10-23 | 2024-10-23 | GALT | ELDRED KARY | Dir | P - Purchase | $2.60 | +500 | 50.2K | +1% | +$1,300 | |
| 2024-10-17 | 2024-10-17 | GALT | FREEMAN KEVIN D | Dir | P - Purchase | $2.64 | +1,300 | 34.8K | +4% | +$3,432 | |
| 2024-10-16 | 2024-10-16 | GALT | FREEMAN KEVIN D | Dir | P - Purchase | $2.70 | +5,000 | 33.5K | +18% | +$13.5K | |
| I | 2024-10-16 | 2024-10-16 | GALT | FREEMAN KEVIN D | Dir | P - Purchase | $2.70 | +5,000 | 80.0K | +7% | +$13.5K |
| I | 2024-08-26 | 2024-08-23 | GALT | Zordani Richard A. Jr. | Dir | P - Purchase | $2.30 | +1,000 | 2,000 | +100% | +$2,300 |
| M | 2024-08-26 | 2024-08-22+ | GALT | Zordani Richard A. Jr. | Dir | P - Purchase | $2.30 | +2,500 | 32.1K | +8% | +$5,750 |
| A | 2024-07-23 | 2024-07-22 | GALT | ELDRED KARY | Dir | P - Purchase | $2.39 | +400 | 49.7K | +0.8% | +$956 |
| 2024-07-23 | 2024-01-16 | GALT | ELDRED KARY | Dir | P - Purchase | $2.39 | +400 | 49.7K | +0.8% | +$956 | |
| 2024-06-20 | 2024-06-20 | GALT | FREEMAN KEVIN D | Dir | P - Purchase | $2.38 | +2,500 | 28.5K | +10% | +$5,950 | |
| I | 2024-04-30 | 2024-04-30 | GALT | Zordani Richard A. Jr. | Dir | P - Purchase | $3.52 | +1,000 | 1,000 | New | +$3,520 |
| I | 2024-04-25 | 2024-04-24 | GALT | LEWIS JOEL | Pres, CEO, Dir | P - Purchase | $3.39 | +1,000 | 2,000 | +100% | +$3,390 |
| MI | 2024-04-25 | 2024-04-22+ | GALT | CZIRR JAMES C | 10% | S - Sale | $3.06 | -25.0K | 5.92M | -0.4% | -$76.5K |
| 2024-04-22 | 2024-04-22 | GALT | FREEMAN KEVIN D | Dir | P - Purchase | $2.98 | +2,500 | 26.0K | +11% | +$7,450 | |
| I | 2024-04-09 | 2024-04-09 | GALT | FREEMAN KEVIN D | Dir | W - Inherited | $0.00 | +2,063 | 18.1K | +13% | $0 |
| 2024-03-04 | 2024-03-01 | GALT | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.96 | -152.6K | 897.7K | -15% | -$299.1K | |
| D | 2024-02-07 | 2024-01-24 | GALT | Uihlein Richard E | Dir, 10% | A - Grant | $1.72 | +23.3K | 10.27M | +0.2% | +$40.0K |
| 2024-01-16 | 2024-01-16 | GALT | ELDRED KARY | Dir | P - Purchase | $1.79 | +500 | 49.3K | +1% | +$895 | |
| 2024-01-02 | 2023-12-29 | GALT | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.66 | +11.6K | 1.04M | +1% | +$19.3K | |
| 2023-12-18 | 2023-12-15 | GALT | LEWIS JOEL | Pres, CEO, Dir | A - Grant | $1.60 | +12.0K | 1.03M | +1% | +$19.3K |
Purchase Sale Sale after option exercise All abbreviations